217 related articles for article (PubMed ID: 18650353)
1. Metronidazole resistance in Clostridium difficile is heterogeneous.
Peláez T; Cercenado E; Alcalá L; Marín M; Martín-López A; Martínez-Alarcón J; Catalán P; Sánchez-Somolinos M; Bouza E
J Clin Microbiol; 2008 Sep; 46(9):3028-32. PubMed ID: 18650353
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997.
Barbut F; Decré D; Burghoffer B; Lesage D; Delisle F; Lalande V; Delmée M; Avesani V; Sano N; Coudert C; Petit JC
Antimicrob Agents Chemother; 1999 Nov; 43(11):2607-11. PubMed ID: 10543736
[TBL] [Abstract][Full Text] [Related]
3. Fluoroquinolone resistance and Clostridium difficile, Germany.
Zaiss NH; Witte W; Nübel U
Emerg Infect Dis; 2010 Apr; 16(4):675-7. PubMed ID: 20350385
[TBL] [Abstract][Full Text] [Related]
4. A multicenter-based study on epidemiology, antibiotic susceptibility and risk factors of toxigenic Clostridium difficile in hospitalized patients in southwestern Iran.
Sedigh Ebrahim-Saraie H; Heidari H; Amanati A; Bazargani A; Alireza Taghavi S; Nikokar I; Kalantar K; Motamedifar M
Infez Med; 2018 Dec; 26(4):308-315. PubMed ID: 30555133
[TBL] [Abstract][Full Text] [Related]
5. Detection of Plasmid-Mediated Resistance to Metronidazole in Clostridioides difficile from River Water.
Cizek A; Masarikova M; Mares J; Brajerova M; Krutova M
Microbiol Spectr; 2022 Aug; 10(4):e0080622. PubMed ID: 35950844
[TBL] [Abstract][Full Text] [Related]
6. Emergence of reduced susceptibility to metronidazole in Clostridium difficile.
Baines SD; O'Connor R; Freeman J; Fawley WN; Harmanus C; Mastrantonio P; Kuijper EJ; Wilcox MH
J Antimicrob Chemother; 2008 Nov; 62(5):1046-52. PubMed ID: 18693234
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital.
Aspevall O; Lundberg A; Burman LG; Akerlund T; Svenungsson B
Antimicrob Agents Chemother; 2006 May; 50(5):1890-2. PubMed ID: 16641471
[TBL] [Abstract][Full Text] [Related]
8. The emergence of metronidazole and vancomycin reduced susceptibility in Clostridium difficile isolates in Iran.
Kouhsari E; Douraghi M; Krutova M; Fakhre Yaseri H; Talebi M; Baseri Z; Moqarabzadeh V; Sholeh M; Amirmozafari N
J Glob Antimicrob Resist; 2019 Sep; 18():28-33. PubMed ID: 30703583
[TBL] [Abstract][Full Text] [Related]
9. Analysis of metronidazole susceptibility in different Clostridium difficile PCR ribotypes.
Moura I; Spigaglia P; Barbanti F; Mastrantonio P
J Antimicrob Chemother; 2013 Feb; 68(2):362-5. PubMed ID: 23104495
[TBL] [Abstract][Full Text] [Related]
10. Metronidazole resistance in Bacteroides spp. carrying nim genes and the selection of slow-growing metronidazole-resistant mutants.
Gal M; Brazier JS
J Antimicrob Chemother; 2004 Jul; 54(1):109-16. PubMed ID: 15190033
[TBL] [Abstract][Full Text] [Related]
11. Multidisciplinary analysis of a nontoxigenic Clostridium difficile strain with stable resistance to metronidazole.
Moura I; Monot M; Tani C; Spigaglia P; Barbanti F; Norais N; Dupuy B; Bouza E; Mastrantonio P
Antimicrob Agents Chemother; 2014 Aug; 58(8):4957-60. PubMed ID: 24913157
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
Debast SB; Bauer MP; Sanders IM; Wilcox MH; Kuijper EJ;
J Antimicrob Chemother; 2013 Jun; 68(6):1305-11. PubMed ID: 23420839
[TBL] [Abstract][Full Text] [Related]
13. Diversity of Circulating
Martínez-Meléndez A; Tijerina-Rodríguez L; Collins N; Baines SD; Morfin-Otero R; Camacho-Ortíz A; Villarreal-Treviño L; Garza-González E
Microb Drug Resist; 2021 Dec; 27(12):1672-1676. PubMed ID: 34037477
[TBL] [Abstract][Full Text] [Related]
14. Isolation of Clostridium difficile from dogs with digestive disorders, including stable metronidazole-resistant strains.
Orden C; Blanco JL; Álvarez-Pérez S; Garcia-Sancho M; Rodriguez-Franco F; Sainz A; Villaescusa A; Harmanus C; Kuijper E; Garcia ME
Anaerobe; 2017 Feb; 43():78-81. PubMed ID: 27965048
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of linezolid against Clostridium difficile.
Peláez T; Alonso R; Pérez C; Alcalá L; Cuevas O; Bouza E
Antimicrob Agents Chemother; 2002 May; 46(5):1617-8. PubMed ID: 11959617
[TBL] [Abstract][Full Text] [Related]
16. Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile.
Huhulescu S; Sagel U; Fiedler A; Pecavar V; Blaschitz M; Wewalka G; Allerberger F; Indra A
J Med Microbiol; 2011 Aug; 60(Pt 8):1206-1212. PubMed ID: 21292853
[TBL] [Abstract][Full Text] [Related]
17. Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.
Peláez T; Alcalá L; Alonso R; Rodríguez-Créixems M; García-Lechuz JM; Bouza E
Antimicrob Agents Chemother; 2002 Jun; 46(6):1647-50. PubMed ID: 12019070
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest.
Wong SS; Woo PC; Luk WK; Yuen KY
Diagn Microbiol Infect Dis; 1999 May; 34(1):1-6. PubMed ID: 10342100
[TBL] [Abstract][Full Text] [Related]
19. Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile.
Boekhoud IM; Sidorov I; Nooij S; Harmanus C; Bos-Sanders IMJG; Viprey V; Spittal W; Clark E; Davies K; Freeman J; Kuijper EJ; Smits WK;
J Antimicrob Chemother; 2021 Jun; 76(7):1731-1740. PubMed ID: 33876817
[TBL] [Abstract][Full Text] [Related]
20. High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
Cheng JW; Yang QW; Xiao M; Yu SY; Zhou ML; Kudinha T; Kong F; Liao JW; Xu YC
J Microbiol Immunol Infect; 2018 Jun; 51(3):411-416. PubMed ID: 28693926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]